Evaluating the neuroprotective impact of senolytic drugs on human vision
Nevin W. El-Nimri, Spencer M. Moore, Linda M. Zangwill, James A. Proudfoot, Robert N. Weinreb, Dorota Skowronska-Krawczyk, Sally L. Baxter
doi: https://doi.org/10.1101/2020.07.27.20163097
Nevin W. El-Nimri
1Viterbi Family Department of Ophthalmology, Shiley Eye Institute, and Hamilton Glaucoma Center, University of California San Diego, 9415 Campus Point Drive, La Jolla, CA, 92093 USA
Spencer M. Moore
1Viterbi Family Department of Ophthalmology, Shiley Eye Institute, and Hamilton Glaucoma Center, University of California San Diego, 9415 Campus Point Drive, La Jolla, CA, 92093 USA
Linda M. Zangwill
1Viterbi Family Department of Ophthalmology, Shiley Eye Institute, and Hamilton Glaucoma Center, University of California San Diego, 9415 Campus Point Drive, La Jolla, CA, 92093 USA
James A. Proudfoot
1Viterbi Family Department of Ophthalmology, Shiley Eye Institute, and Hamilton Glaucoma Center, University of California San Diego, 9415 Campus Point Drive, La Jolla, CA, 92093 USA
Robert N. Weinreb
1Viterbi Family Department of Ophthalmology, Shiley Eye Institute, and Hamilton Glaucoma Center, University of California San Diego, 9415 Campus Point Drive, La Jolla, CA, 92093 USA
Dorota Skowronska-Krawczyk
1Viterbi Family Department of Ophthalmology, Shiley Eye Institute, and Hamilton Glaucoma Center, University of California San Diego, 9415 Campus Point Drive, La Jolla, CA, 92093 USA
3Department of Physiology and Biophysics, Department of Ophthalmology, Center for Translational Vision Research, University of California Irvine, Irvine, CA
Sally L. Baxter
1Viterbi Family Department of Ophthalmology, Shiley Eye Institute, and Hamilton Glaucoma Center, University of California San Diego, 9415 Campus Point Drive, La Jolla, CA, 92093 USA
2Health Department of Biomedical Informatics, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA
Data Availability
All data referred to in the manuscript came from patients medical charts and secure healthcare software (EPIC). The processed data is saved in a secure university drive with protected password.
Posted November 25, 2020.
Evaluating the neuroprotective impact of senolytic drugs on human vision
Nevin W. El-Nimri, Spencer M. Moore, Linda M. Zangwill, James A. Proudfoot, Robert N. Weinreb, Dorota Skowronska-Krawczyk, Sally L. Baxter
medRxiv 2020.07.27.20163097; doi: https://doi.org/10.1101/2020.07.27.20163097
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)